Ipilimumab vs Tamoxifen
Ipilimumab vs Tamoxifen: Overview
This comparison examines the pharmacological differences between Ipilimumab and Tamoxifen.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Tamoxifen: Selective estrogen receptor modulator (SERM).
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Tamoxifen — 5-7 days.
Chemical Properties
Molecular Formula: Tamoxifen — C26H29NO.
Molecular Weight: Tamoxifen — 371.5150 g/mol.
Type: Ipilimumab — Antibody; Tamoxifen — Small molecule.